立体复杂化和结晶性对聚酸纳米颗粒降解的影响
Chuan Yin1, Jenny Hemstedt1, Karl Scheuer1
1Chair of Material Science (CMS), Otto Schott Institute for Materials Research (OSIM), Friedrich Schiller University Jena, Löbdergraben 32, 07743 Jena, Germany.
Nanomaterials (Basel, Switzerland)
|March 12, 2024
概括
聚合物纳米粒子 (PNPs) 的降解可以通过改变它们的化学结构和结晶性来控制. 这项研究表明,不同的聚甲基化物 (PNP) 含量如何影响PNP水解,为先进的药物输送系统提供了见解.
科学领域:
- 材料科学 材料科学 材料科学
- 聚合物化学 聚合物化学
- 纳米技术 纳米技术
背景情况:
- 聚合物纳米粒子 (PNPs) 在药物输送系统中至关重要.
- 聚烯降解受到聚合物结构,大小,结晶度和化温度的影响.
- 了解PNP降解是优化药物递送功效的关键.
研究的目的:
- 研究聚合物纳米粒子 (PNPs) 的酶解水解和降解.
- 探索不同晶度和化学结构对PNP降解的影响.
- 分析蛋白酶K对PNP降解机制的影响.
主要方法:
- 使用纳米沉方法制备PNP.
- 合成聚3-乙基化物 (PEtGly) 以控制立体复合物 (SC) 的结晶性和化温度.
- 利用原子力显微镜 (AFM) 和石英晶微平衡与分散监测 (QCM-D) 来分析降解.
主要成果:
- 通过化学结构,结晶性和立体复杂化来控制PNP的降解.
- 较高的EtGly含量导致7天后降解加速,表明较低的结晶度增加了水解易感性.
- 具有较高结晶度和较低EtGly含量的SC-PNPs显示酶吸附率降低和降解速度减慢.
- 飞机机械显示了延迟的降解变化,而QCM-D从一开始就检测到快速的降解.
结论:
- 聚烯降解受到聚合物结晶性和化学成分的显著影响.
- 立体复合和受控的结晶性提供调节PNP降解速率的途径.
- 这些发现为设计具有针对药物输送量身定制的降解特性的先进PNP提供了宝贵的知识.
相关概念视频
Polymer Classification: Stereospecificity
2.4K
Polymerization generates chiral centers along the entire backbone of a polymer chain. Accordingly, the stereochemistry of the substituent group has a significant effect on polymer properties. Polymers formed from monosubstituted alkene monomers feature chiral carbons at every alternate position in the polymer backbone. Relative to the predominant orientation of substituents at the adjacent chiral carbons, the polymer can exist in three different configurations: isotactic, syndiotactic, and...
2.4K
Polymer Classification: Crystallinity
2.9K
Unlike ionic or small covalent molecules, polymers do not form crystalline solids due to the diffusion limitations of their long-chain structures. However, polymers contain microscopic crystalline domains separated by amorphous domains.
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
Crystalline domains are the regions where polymer chains are aligned in an orderly manner and held together in proximity by intermolecular forces. For example, chains in the crystalline domains of polyethylene and nylon are bound together by van der Waals...
2.9K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
308
Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
308
Polymer Classification: Architecture
2.7K
Polymers are classified as linear or branched on the basis of their chain architecture. The polymer chains in linear polymers have a long chain-like structure with minimal to no branching at all. Even if a polymer features large substituent groups on the monomer, which appear as branches to the skeleton, it is not considered a branched polymer. A branched polymer contains secondary polymer chains that arise from the main polymer chain. The branching occurs when the polymer growth shifts from...
2.7K
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
207
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
207


